Table 2.
Details of products collected in study
| API | Samples | Brands | Unique products (brand and dose) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Branded | INN | Total | Branded | INN | Total | Branded | INN | Total | |
| Amlodipine | 35 | 53 | 88 | 14 | 16 | 30 | 18 | 22 | 40 |
| Captopril | 8 | 14 | 22 | 1 | 4 | 5 | 1 | 6 | 7 |
| Furosemide | 11 | 10 | 21 | 4 | 4 | 8 | 4 | 4 | 8 |
| Glibenclamide | 9 | 12 | 21 | 4 | 4 | 8 | 4 | 2 | 6 |
| Simvastatin | 19 | 33 | 52 | 6 | 11 | 17 | 7 | 15 | 22 |
| Total | 82 | 122 | 204 | 29 | 39 | 68 | 36 | 49 | 83 |
API = active pharmaceutical ingredient; INN = International Non-proprietary Name.